BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 492058)

  • 1. [Pharmacological treatment of chronic arterial occlusive disease (author's transl)].
    Dittrich J; Spaan G; Stein U; Wagner E; Frese JH
    Med Klin; 1979 Sep; 74(39):1396-403. PubMed ID: 492058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H
    Med Klin; 1978 May; 73(21):798-800. PubMed ID: 651769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H; Schmidt P; Hüttel E
    MMW Munch Med Wochenschr; 1978 Nov; 120(45):1501-4. PubMed ID: 101819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoids in therapy of peripheral arterial occlusive disease.
    Creutzig A; Caspary L
    Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of peripheral arterial occlusive disease: clinical, haemodynamic and metabolic investigation (author's transl)].
    Matthes D; Mörl H
    Dtsch Med Wochenschr; 1979 May; 104(21):772-5. PubMed ID: 446295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H
    Fortschr Med; 1980 Feb; 98(7):257-60. PubMed ID: 6767648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methodology in angiologic-therapeutic-clinical research. Inter- and intra-individual comparison in arterial occlusive disease].
    Maass U
    Fortschr Med; 1983 Oct; 101(40):1831-7. PubMed ID: 6642390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long term results of intraarterial infusion therapy in peripheral arterial occlusive diseases].
    Hild R; Spaan G; Stein U
    Med Welt; 1981 Apr; 32(14):448-51. PubMed ID: 7219157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effective therapy of chronic arterial circulatory disorders with Nico-Padutin forte (author's transl)].
    Vorberg G
    MMW Munch Med Wochenschr; 1976 Oct; 118(44):1429-32. PubMed ID: 825753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with Arwin (author's transl)].
    Hess H; Keil-Kuri E; Marshall M
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1317-20. PubMed ID: 819792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease].
    Diehm C; Mörl H; Schettler G
    Z Kardiol; 1983 Jan; 72(1):44-7. PubMed ID: 6837085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate and pyruvate changes during treadmill exercise in patients with intermittent claudication.
    Maass U; Alexander K
    Z Kardiol; 1982 Jan; 71(1):39-43. PubMed ID: 7064501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 19. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.